- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Lung Small Cell Carcinoma in Taiwan
Total 853 results
-
National Cancer Institute (NCI)CompletedMetastatic Lung Non-Squamous Non-Small Cell Carcinoma | Recurrent Lung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7United States
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Janssen Research & Development, LLCActive, not recruitingAdvanced or Metastatic Non-small Cell Lung CancerItaly, United States, Germany, Japan, China, Korea, Republic of, Israel, Portugal, Taiwan, Thailand, Malaysia, United Kingdom, Australia, Turkey, Poland, Spain, Brazil, Canada, Argentina, France
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
OBI Pharma, IncRecruiting
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Tianjin Medical University Cancer Institute and...Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Pierre Fabre MedicamentActive, not recruiting
-
Shandong Provincial HospitalUnknown
-
AmgenNo longer availableNon Small-cell Lung Cancer | Locally Advanced Unresectable NSCLC | Locally Advanced Metastatic NSCLCUnited States, Taiwan, Israel, Saudi Arabia, Brazil, Argentina
-
AstraZenecaCompletedNon-small-cell Lung Cancer (NSCLC)Mexico, Peru, Argentina, Taiwan, India, Thailand, Colombia, Uruguay, Chile, Dominican Republic
-
Cancer Institute and Hospital, Chinese Academy...RecruitingLimited Stage Small Cell Lung CancerChina
-
SanofiTerminatedProstate Cancer | Non-small Cell Lung CancerTaiwan, United States, France, Italy, United Kingdom
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of, Taiwan, Singapore, Japan
-
Chang Gung Memorial HospitalCompletedAdvanced Nonsmall Cell Lung CancerTaiwan
-
PfizerCompletedNSCLC (Non-small Cell Lung Cancer)Hong Kong, China, Taiwan, Malaysia, Thailand
-
National Cancer Institute (NCI)Active, not recruitingStage IV Lung Cancer AJCC v8 | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Recurrent Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
AVEO Pharmaceuticals, Inc.CompletedLung Neoplasms | Respiratory Tract Neoplasms | Lung Cancer | Carcinoma, Non-Small Cell-LungHong Kong, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand
-
National Cancer Institute (NCI)RecruitingStage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Recurrent Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Regeneron PharmaceuticalsSanofiTerminatedAdvanced Non-Small Cell Lung CarcinomaUnited States, Belgium, France, Germany, Korea, Republic of, Poland, Spain, Taiwan, United Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, China, Korea, Republic of, Canada, Japan, Netherlands, Italy
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerCanada, Spain, Australia, Singapore, Germany, Italy, Korea, Republic of, Norway, Taiwan, United States, France
-
Impact Therapeutics, Inc.RecruitingSmall Cell Lung Cancer | Advanced Solid TumoursTaiwan, Korea, Republic of, China, Australia, United States
-
Merck KGaA, Darmstadt, GermanyTerminatedNon-Small Cell Lung CancerKorea, Republic of, Taiwan, Singapore, China, Hong Kong
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerChina, Taiwan, Belgium, Netherlands, Spain, Germany, Singapore, Italy, Japan, Australia, Israel, Korea, Republic of, Thailand, France
-
AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungTaiwan
-
AmgenCompletedSquamous-Cell Non-Small-Cell Lung CancerFrance, Belgium, Spain, United States, Taiwan, Korea, Republic of, Japan, Poland
-
National Cancer Institute (NCI)Active, not recruitingExtensive Stage Lung Small Cell CarcinomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Non Small Cell Lung CancerDenmark, United States, Argentina, Australia, Austria, Belgium, Brazil, Finland, France, Germany, Israel, Italy, Korea, Republic of, Malaysia, Poland, Russian Federation, Spain, Switzerland, Taiwan, Thailand
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerGermany, Taiwan, Australia, China, Korea, Republic of
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, United Kingdom, Spain
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Lung Small Cell CarcinomaUnited States, Canada, Korea, Republic of, Mexico
-
National Cancer Institute (NCI)NRG OncologyRecruitingExtensive Stage Lung Small Cell CarcinomaUnited States
-
AstraZenecaCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United Kingdom, Spain, United States, Netherlands
-
AbbViePfizerActive, not recruitingCancer | Non-small Cell Lung Cancer (NSCLC)United States, Israel, Japan, Korea, Republic of, Spain, Taiwan
-
PfizerOxOnc Development LPCompletedNon Small Cell Lung Cancer | Crizotinib | ROS1 Proto OncogeneKorea, Republic of, China, Taiwan, Japan
-
Novartis PharmaceuticalsCompletedNon-Small-Cell Lung CancerGreece, Taiwan, Germany, Belgium, Italy, Spain, United Kingdom, Korea, Republic of, Netherlands, China, Hungary, Poland, France, Thailand, Portugal
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalNational Science Council, TaiwanUnknownCarcinoma, Non-Small-Cell Lung | ChemotherapyTaiwan
-
National Taiwan University HospitalUnknown
-
National Health Research Institutes, TaiwanChina Medical University Hospital; Chang Gung Memorial Hospital; National Cheng-Kung... and other collaboratorsCompleted
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
BeiGeneActive, not recruitingNon Small Cell Lung CancerChina
-
National Taiwan University HospitalUnknownLung Cancer, Nonsmall CellTaiwan
-
Cancer Institute and Hospital, Chinese Academy...Jiangsu Hansoh Pharmaceutical Co., Ltd.; GeneCast Biotechnology Co., Ltd.Enrolling by invitation
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerSpain, France, United States, Taiwan, Canada, Netherlands, Mexico